Trial Profile
Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study: Phase I
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary)
- Indications Respiratory distress syndrome
- Focus Adverse reactions; Therapeutic Use
- 19 Nov 2013 New trial record